GraMedica establishes European headquarters in Poland.
- Feb. 15, 2018
-- The mission of "Changing lives, one foot at a time" has expanded globally with Michigan-based GraMedica's opening of a permanent EU Office. Increasing awareness of the importance of foot heath and alignment Worldwide is the focus of this expansion. The EU office serves increasing demand for GraMedica foot care solutions by European orthopedic and podiatric surgeons- primarily the flagship HyProCure®
line. A patented titanium stent that instantly corrects certain hindfoot disorders that are well known to cause back pain and otherwise compromise quality of life. The minimally invasive HyProCure®
is used in both children and adults.
Poland was chosen due to it's central location and desirability as an emerging EU country. This follows GraMedica opening an Asian headquarters in Shanghai last year.
GraMedica is a global medical device company that's passionate about creating innovative foot and ankle products that improve patient options and outcomes. We educate foot and ankle surgeons in over 70 countries. We are committed to helping create ongoing improvement in the quality of healthcare for both patients and physicians through premier product lines including the Soleus Foot Care Collection, opti-toe®
digital implant, HyProCure®
sinus tarsi stent, and osteo-WEDGE®
locking plate system. To learn more about GraMedica, please visit our website at www.gramedica.com